Key data
| Regulation | Royal Decree 930/2026, of October 28 |
|---|---|
| BOE Publication | October 30, 2026 |
| Entry into force | October 30, 2026 |
| Beneficiary | Associació pels Drets Sexuals i Reproductius |
| Purpose | Strengthening of the "Quiero Abortar" resource and training for healthcare professionals |
| Type of grant | Direct, without competitive bidding |
| Category | Grants and Subsidies |
| Legal framework | LO 2/2010 and its reform by LO 1/2023 |
| Context data | Only 21.25% of voluntary pregnancy interruptions were performed in public centers in 2024 |
The State directly finances a private initiative from the third sector to cover a gap that the public system itself is not resolving. In 2024, barely 1 in 5 IVE was performed in an NHS center, which evidences persistent territorial inequalities in access to a right recognized by LO 2/2010, reformed by LO 1/2023. The Royal Decree 930/2026 formalizes the response: a direct subsidy to the Associació pels Drets Sexuals i Reproductius to strengthen the "Quiero Abortar" platform and extend support to health professionals involved in the practice of sexual and reproductive rights.
What does this regulation establish?
Royal Decree 930/2026 regulates the direct grant of a state subsidy to the Associació pels Drets Sexuals i Reproductius, a third-sector entity specialized in sexual and reproductive health, for two specific lines of action:
| Line of action | Description |
|---|---|
| Strengthening of "Quiero Abortar" | Expansion of web information by provinces and strengthening of individual support for women seeking access to IVE |
| Extension to healthcare professionals | Creation of training resources, clinical protocols and materials for NHS professionals involved in the practice of sexual and reproductive rights |
The grant is direct, meaning it does not go through an open competitive bidding process available to other entities. The legal justification is the singular and pioneering nature of the project at the state level: there is no other equivalent initiative in Spain that combines territorial information by provinces with individual support and specific training for healthcare professionals in this field.
The regulatory framework that obliges the State to act is LO 2/2010 on sexual and reproductive health and voluntary pregnancy interruption, and its reform through LO 1/2023, which strengthen the obligation to guarantee equal access to IVE within the National Health System.
Economic and operational impact
This regulation does not generate direct costs for private companies. Its economic and operational impact is concentrated in three areas:
- Public spending: The State assumes the full cost of the subsidy through a direct grant, without other entities being able to compete for those funds. The specific amount of the subsidy is not specified in the published data.
- Public-private collaboration model: A model is consolidated in which the State outsources to the third sector a function that the NHS does not cover sufficiently. This may set a precedent for other entities in the sexual and reproductive health sector.
- Operational burden for NHS centers: The creation of clinical protocols and training materials means that public health centers will have to integrate and apply these resources in their internal processes, with the consequent impact on staff training.
The underlying structural data is relevant: with only 21.25% of IVE in public centers in 2024, the pressure on the private network and territorial inequalities are the problem that this subsidy attempts to correct from the side of information and support.
Who does it affect?
- Healthcare professionals in the NHS involved in the practice of IVE: will receive new training resources, clinical protocols and specific materials developed with the subsidy.
- Women seeking access to IVE: information available on the "Quiero Abortar" platform is expanded, with breakdown by provinces, and individual support is strengthened.
- Third-sector entities in sexual and reproductive health: the direct grant model without competitive bidding establishes a precedent on how the State can finance "singular" projects in this field, without opening a public call.
- Public health centers: will have to incorporate the protocols and training materials generated with this subsidy.
- Managers and public health program coordinators in autonomous communities: the expansion of information by provinces affects the territorial planning of IVE services.
Practical example
A public hospital in an autonomous community with a low rate of IVE in public centers—below the 21.25% average recorded in 2024—receives through its nursing management the new clinical protocols and training materials developed by the Associació pels Drets Sexuals i Reproductius with this subsidy.
The center's training manager must plan sessions for staff involved in IVE practice, using these materials. At the same time, the "Quiero Abortar" platform updates its information for that province, which may result in an increase in consultations and referrals to that center. The hospital does not assume direct economic cost for the materials—financed by the state subsidy—but must manage the training time for affected staff.
What should organizations do now?
- NHS health centers: Identify the training manager who will manage the incorporation of new clinical protocols and training materials when available.
- Nursing and medical management: Plan in advance training sessions for staff involved in IVE practice, anticipating the arrival of resources developed with this subsidy.
- Third-sector entities in sexual health: Analyze the direct grant model used in this Royal Decree if they are developing projects of singular character at the state level, as it may be a precedent applicable to future public funding requests.
- Territorial planning managers in autonomous communities: Review IVE data in public centers in your territory—comparing with the national average of 21.25% in 2024—to anticipate the impact of the expansion of provincial information on the "Quiero Abortar" platform.
- Public health program managers: Monitor the publication of materials and protocols generated with this subsidy to integrate them into continuous training plans for healthcare staff.
Frequently asked questions
Why is this subsidy granted directly and not through a public tender?
Royal Decree 930/2026 justifies the direct grant—without competitive bidding—in the singular and pioneering nature of the project at the state level. There is no other equivalent initiative in Spain that combines territorial information by provinces, individual support and specific training for healthcare professionals in IVE matters, which prevents applying the ordinary competitive procedure.
What percentage of IVE are currently performed in NHS public centers?
According to data collected in Royal Decree 930/2026, in 2024 only 21.25% of voluntary pregnancy interruptions were performed in NHS public centers. This data evidences persistent territorial inequalities and is the main justification for the subsidy.
What obligations does this regulation generate for NHS healthcare professionals?
The subsidy will finance the creation of training resources, clinical protocols and specific materials for health professionals involved in the practice of sexual and reproductive rights. NHS centers will have to integrate these materials into their internal training processes, although the Royal Decree does not establish specific deadlines or sanctions for non-compliance in the published data.
What is the "Quiero Abortar" platform and what changes with this subsidy?
"Quiero Abortar" is an information and support platform on voluntary pregnancy interruption managed by the Associació pels Drets Sexuals i Reproductius. With this subsidy, web information is expanded with breakdown by provinces and individual support for women seeking access to IVE is strengthened.
Can other third-sector entities apply for similar funding?
Not within the framework of this Royal Decree, as the grant is direct and exclusive to the Associació pels Drets Sexuals i Reproductius. However, the model used—direct grant for singular project character—can serve as a reference for other entities in the sexual and reproductive health sector that develop unique projects at the state level to request public funding under the same legal protection.
Official source
Consult complete regulation in official source
Notice: This article is merely informative in nature and does not constitute legal advice. For specific decisions, consult a qualified professional. Source: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2026-22718